Cargando…

Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine

SIMPLE SUMMARY: Immune-oncology has revolutionized the natural history of many cancers in the past decade, becoming a new therapeutic weapon. The identification of immune “checkpoints” (PD-1/CTLA-4) whose blockade stimulates anti-tumor immunity has changed outcomes for many ptients. However, immune...

Descripción completa

Detalles Bibliográficos
Autores principales:	Longhitano, Elisa, Muscolino, Paola, Lo Re, Claudia, Ferrara, Serena Ausilia, Cernaro, Valeria, Gembillo, Guido, Tessitore, Dalila, Speranza, Desirèe, Figura, Francesco, Santarpia, Mariacarmela, Silvestris, Nicola, Santoro, Domenico, Franchina, Tindara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046877/ https://www.ncbi.nlm.nih.gov/pubmed/36980777 http://dx.doi.org/10.3390/cancers15061891

Ejemplares similares

Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario
por: Spagnolo, Calogera Claudia, et al.
Publicado: (2022)

Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System
por: Barbieri, Maria Antonietta, et al.
Publicado: (2023)

Phosphate Control in Peritoneal Dialysis Patients: Issues, Solutions, and Open Questions
por: Cernaro, Valeria, et al.
Publicado: (2023)

Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2022)

Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System
por: Barbieri, Maria Antonietta, et al.
Publicado: (2023)

Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database
por: Russo, Giulia, et al.
Publicado: (2023)

Complement Inhibition Therapy and Dialytic Strategies in Paroxysmal Nocturnal Hemoglobinuria: The Nephrologist’s Opinion
por: Gembillo, Guido, et al.
Publicado: (2020)

Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease
por: Calabrese, Vincenzo, et al.
Publicado: (2022)

Kidney Biopsy in Type 2 Diabetic Patients: Critical Reflections on Present Indications and Diagnostic Alternatives
por: Santoro, Domenico, et al.
Publicado: (2021)

Protective Role of Vitamin D in Renal Tubulopathies
por: Gembillo, Guido, et al.
Publicado: (2020)

Role of Vitamin D Status in Diabetic Patients with Renal Disease
por: Gembillo, Guido, et al.
Publicado: (2019)

Maternal and Fetal Outcomes of Pregnancy in Nephrotic Syndrome Due to Primary Glomerulonephritis
por: Siligato, Rossella, et al.
Publicado: (2020)

Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do
por: Zito, Concetta, et al.
Publicado: (2022)

Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy
por: Lucchesi, Simona, et al.
Publicado: (2017)

Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy
por: Lucchesi, Simona, et al.
Publicado: (2017)

Cardiorenal Syndrome: New Pathways and Novel Biomarkers
por: Gembillo, Guido, et al.
Publicado: (2021)

Understanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpoints
por: Karachaliou, Niki, et al.
Publicado: (2015)

Tumor immune microenvironment characterization and response to anti-PD-1 therapy
por: Santarpia, Mariacarmela, et al.
Publicado: (2015)

Autoimmunity and Infection in Glomerular Disease
por: Casuscelli, Chiara, et al.
Publicado: (2023)

Xanthine Oxidase Inhibitors for Improving Renal Function in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis
por: Pisano, Anna, et al.
Publicado: (2017)

Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis
por: Bolignano, Davide, et al.
Publicado: (2017)

Glomerular Filtration Rate as a Predictor of Outcome in Acute Coronary Syndrome Complicated by Atrial Fibrillation
por: Santoro, Domenico, et al.
Publicado: (2020)

Personalized Medicine in Kidney Disease
por: Gembillo, Guido, et al.
Publicado: (2023)

Clinical Evaluation of the Safety, Efficacy and Tolerability of Lanthanum Carbonate in the Management of Hyperphosphatemia in Patients with End-Stage Renal Disease
por: Cernaro, Valeria, et al.
Publicado: (2020)

Lung Dysfunction and Chronic Kidney Disease: A Complex Network of Multiple Interactions
por: Gembillo, Guido, et al.
Publicado: (2023)

Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2021)

Mosaicism in von Hippel-Lindau disease: an event important to recognize
por: Santarpia, Libero, et al.
Publicado: (2007)

Predicting immune checkpoint inhibitor response in urothelial carcinoma: another step in personalised medicine?
por: Niegisch, Günter
Publicado: (2019)

Vitamin D and Glomerulonephritis
por: Gembillo, Guido, et al.
Publicado: (2021)

Amyloidosis and Glomerular Diseases in Familial Mediterranean Fever
por: Siligato, Rossella, et al.
Publicado: (2021)

Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases
por: Ricciardi, Giuseppina Rosaria Rita, et al.
Publicado: (2015)

Heterogeneous Responses to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) in Patients with Uncommon EGFR Mutations: New Insights and Future Perspectives in this Complex Clinical Scenario
por: Russo, Alessandro, et al.
Publicado: (2019)

Mechanisms of resistance to osimertinib
por: Lazzari, Chiara, et al.
Publicado: (2020)

The Aggressive Diabetic Kidney Disease in Youth-Onset Type 2 Diabetes: Pathogenetic Mechanisms and Potential Therapies
por: Amatruda, Michela, et al.
Publicado: (2021)

Potential predictive role of gut microbiota to immunotherapy in HCC patients: a brief review
por: Muscolino, Paola, et al.
Publicado: (2023)

KRAS driven expression signature has prognostic power superior to mutation status in non‐small cell lung cancer
por: Nagy, Ádám, et al.
Publicado: (2016)

Capillary leak syndrome induced by neoadjuvant cisplatin and gemcitabine in a patient with bladder cancer
por: Massafra, Marco, et al.
Publicado: (2020)

Overview on Therapeutic Options in Uncommon EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): New Lights for an Unmet Medical Need
por: Pretelli, Giulia, et al.
Publicado: (2023)

Personalised diet
Publicado: (2011)

Personalised Ecology
por: Gaston, Kevin J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_57unjgno34tvj9vu9c96q4ndus